Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Becton, Dickinson and Company

http://www.bd.com/

Latest From Becton, Dickinson and Company

Three OTC COVID-19 Tests Win FDA Clearance After Template Updates

Access Bio’s CareStart COVID-19 Antigen test gives results within 10 minutes, Becton, Dickinson’s BD Veritor within 15 minutes and InBios International’s SCoV-2 Ag Detect within 20 minutes. All three hold emergency use authorizations.

Diagnostics Coronavirus COVID-19

Becton, Dickinson Has First EUA In US For Smartphone-Linked Rapid Antigen Test

BD has EUA for Veritor At-Home COVID-19 rapid antigen test using smartphone vision technology to interpret and digitally display results. Researchers at biotech firms and medical schools measure advantages of at-home use of rapid antigen tests over quantitative real-time polymerase chain reaction tests.

Coronavirus COVID-19 OTC Devices

FDA Grants EUA For BD Blood Collection Tubes To Soften Shortage

Increased demand tied to COVID-19, plus supply chain difficulties, led to the blood collection device shortage, the US agency says.

Regulation FDA

FDA: Some Mesh Brands May Lead To More Complications In Breast Reconstruction Patients

Patients who receive breast reconstructive surgery using some brands of acellular dermal matrix seem to have a higher risk of major complications than those whose surgeries did not use the mesh, says a safety alert from the US FDA.

Safety FDA
See All

Company Information

UsernamePublicRestriction

Register